ロード中...
Efficacy and safety of tafluprost 0.0015% – retrospective analysis of real-world data from the Philippines
PURPOSE: To investigate the IOP lowering effect and safety of tafluprost 0.0015% in a routine clinical setting in the Philippines. PATIENTS AND METHODS: A retrospective review of glaucoma patients receiving tafluprost 0.0015% (BAK 0.001% preserved) with a minimum follow-up of 3 months was conducted....
保存先:
| 出版年: | Clin Ophthalmol |
|---|---|
| 主要な著者: | , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Dove
2019
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6717730/ https://ncbi.nlm.nih.gov/pubmed/31695311 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OPTH.S209942 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|